In chronic liver disease, this could be expressed through significant reduction of clinical outcomes such as the development of cirrhosis and its complications (ascites, hepatic encephalopathy, gastrointestinal hemorrhage), as well as all-cause mortality 7
5 CRS and biomarkers 5.1 Existing biomarkers in CRS The initial definition of CRS was that it is the outcome of interactions between the renal and other circulatory compartments that increased circulating volume, exacerbated symptoms, and disease progression of patients with HF (Rangaswami et al., 2019)
Patients taking insulin or sulfonylureas alongside Ozempic should monitor blood glucose levels carefully during periods of reduced food intake, as the risk of hypoglycaemia may increase
If youre still on a lower dose of Ozempic (e.g., 0.5 mg or 1 mg), your provider may recommend increasing to 2 mg before switching to see if results improve
Elvira-Torales LI, Garcia-Alonso J, Periago-Caston MJ
Not recommended for individuals with certain health conditions or sensitivities
